Bioray Biotech Co., Ltd reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 148.02 million compared to TWD 156.3 million a year ago. Net loss was TWD 7.19 million compared to TWD 0.058 million a year ago. Basic loss per share from continuing operations was TWD 0.27. Diluted loss per share from continuing operations was TWD 0.27.